EUVIMEDEUVIMED entdecken
Leserbrief

Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort

T Guillaume iD, E Puzenat, F Dresco, F Aubin, I Gallais Sérézal

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.18885 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von T Guillaume und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Besançon University Hospital, Besançon, France. Hauptthemen laut MEDLINE: Methylprednisolone, Alopecia Areata. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor, Therapeutic management of severe alopecia aerata (AA) mainly focuses on intravenous methylprednisolone (IVMP) pulse with or without methotrexate (MTX).1,2 However, the longterm patientreported perception and experience of the treatment remain largely unstudied. We have conducted a retrospective study including 39 patients with AA treated by IVMP pulse therapy (IVMP: 3 days in a row, once a month for 3 months) associated or not with MTX (10– 20 mg/week starting at day 0). The response was estimated as follows: absence of regrowth (no response, NR), complete regrowth (CR), and partial regrowth (PR). Response rates to treatment were collected at two time points: first, at the end of infusions (month 3) based on clinical records, and second in December 2021 (last response observed), based on patient selfreport. A minimum of 12 months between the end of corticosteroid therapy and data collection was required. All patients were contacted by a unique investigator (TG) with two questionnaires including the treatment satisfaction questionnaire for medication Received: 5 September 2022 | Accepted: 13 January 2023 DOI: 10.1111/jdv.18885

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylprednisoloneAlopecia AreataHumansMethotrexateRetrospective StudiesPatient Reported Outcome MeasuresPerceptionTreatment Outcome

Substanzen

MethylprednisoloneMethotrexate

Autor:innen und Institutionen

  • Dermatology Department, Besançon University Hospital, Besançon, France.
  • Inserm UMR 1098 RIGHT, Besançon, France.

ORCID-Profile: T Guillaume

Zitieren

APA

Guillaume, T., Puzenat, E., Dresco, F., Aubin, F., & Gallais Sérézal, I. (2023). Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18885

Vancouver

Guillaume T, Puzenat E, Dresco F, Aubin F, Gallais Sérézal I. Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18885

BibTeX
@article{Guillaume2023,
  author = {Guillaume, T and Puzenat, E and Dresco, F and Aubin, F and Gallais Sérézal, I},
  title = {Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.18885}
}
Kostenlos starten →